Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study

No definitive treatment strategy has been established for patients with metastatic colorectal cancer (mCRC) who experienced progression after three or more lines of chemotherapy. A total of 36 mCRC patients were enrolled in this retrospective study who received apatinib therapy under non-clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Miaomiao, Si, Haiyan, Zhang, Yong, Qian, Niansong, Wang, Zhikuan, Shi, Weiwei, Dai, Guanghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854587/
https://www.ncbi.nlm.nih.gov/pubmed/29545575
http://dx.doi.org/10.1038/s41598-018-22302-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854587/
https://www.ncbi.nlm.nih.gov/pubmed/29545575
http://dx.doi.org/10.1038/s41598-018-22302-z

Ejemplares similares